BERGENBIO ASA (BGBIO.OL) Stock Cash Flow
OSL:BGBIO - Euronext Oslo - NO0013251173 - Common Stock - Currency: NOK
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -139.28M | -190.40M | -302.12M | -309.36M | -257.03M | |||
| Depreciation Amortization | 456.00K | 223.00K | 883.00K | 1.31M | 726.00K | |||
| Change In Working Capital | -11.64M | -33.43M | 10.18M | 5.10M | 13.57M | |||
| Other non cash items | -2.78M | -1.49M | 2.83M | -389.00K | 8.44M | |||
| OPERATING CASH FLOW | -153.24M | -225.10M | -288.23M | -303.34M | -234.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | N/A | N/A | -67.00K | |||
| Other Investing Activity | 3.69M | 3.06M | 3.25M | 3.13M | 3.62M | |||
| INVESTING CASH FLOW | 3.69M | 3.06M | 3.25M | 3.13M | 3.55M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -437.00K | -193.00K | -307.00K | -565.00K | -585.00K | |||
| Stock Issued/Repurchased | 138.87M | 262.05M | 3.22M | 16.63M | 700.09M | |||
| Other Financing Activity | -8.83M | -36.97M | -7.00K | -69.00K | N/A | |||
| FINANCING CASH FLOW | 129.61M | 224.88M | 2.90M | 15.99M | 699.51M | |||
| Exchange Rate Effect | 3.68M | 2.78M | -3.76M | -779.00K | -710.00K | |||
| CHANGE IN CASH | -16.27M | 5.62M | -285.84M | -284.99M | 468.06M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -153.24M | -225.10M | -288.23M | -303.34M | -234.29M | |||
| Capital Expenditure | N/A | 0.00 | N/A | N/A | -67.00K | |||
| FREE CASH FLOW | -153.24M | -225.10M | -288.23M | -303.34M | -234.36M | |||
All data in NOK